Compounds > farnesol

farnesol and sirolimus

farnesol has been researched along with sirolimus in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhagatji, P; Leventis, R; Lin, CJ; Rich, R; Silvius, JR1
Belhumeur, P; Shareck, J1
Alperstein, D; Kloog, Y; Kraitzer, A; Zilberman, M1
Ehrlich, M; Gefen-Dor, C; Jacob-Hirsch, J; Kloog, Y; Makovski, V; Rechavi, G; Shai, B1

Reviews

1 review(s) available for farnesol and sirolimus

ArticleYear
Modulation of morphogenesis in Candida albicans by various small molecules.
    Eukaryotic cell, 2011, Volume: 10, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Bacteriocins; Benzoquinones; Candida albicans; Candidiasis; Cell Cycle; Cyclooxygenase Inhibitors; Farnesol; Fatty Acids; Histone Deacetylase Inhibitors; Humans; Lactams, Macrocyclic; Morphogenesis; Sirolimus; Virulence

2011

Other Studies

3 other study(ies) available for farnesol and sirolimus

ArticleYear
Multiple cellular proteins modulate the dynamics of K-ras association with the plasma membrane.
    Biophysical journal, 2010, Nov-17, Volume: 99, Issue:10

    Topics: Amino Acid Sequence; Calmodulin; Cell Membrane; Cyclic Nucleotide Phosphodiesterases, Type 6; Farnesol; Galectin 3; GTP-Binding Proteins; HeLa Cells; Humans; Intracellular Space; Kinetics; Microscopy, Confocal; Molecular Sequence Data; Peptides; Prenylation; Protein Binding; Proto-Oncogene Proteins p21(ras); Salicylates; Sirolimus; Vesicular Transport Proteins

2010
Mechanisms of antiproliferative drug release from bioresorbable porous structures.
    Journal of biomedical materials research. Part A, 2013, Volume: 101, Issue:5

    Topics: Antineoplastic Agents; Biocompatible Materials; Drug-Eluting Stents; Farnesol; Humans; Models, Molecular; Neoplasms; Paclitaxel; Polyglactin 910; Porosity; Salicylates; Sirolimus; Solubility

2013
Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.
    Cell death & disease, 2014, Dec-04, Volume: 5

    Topics: Angiomyolipoma; Cell Proliferation; Farnesol; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Interferon Regulatory Factor-7; Kidney; Lymphangioleiomyomatosis; Microarray Analysis; Monomeric GTP-Binding Proteins; Neuropeptides; Ras Homolog Enriched in Brain Protein; RNA, Small Interfering; Salicylates; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Cells, Cultured; Tumor Suppressor Proteins

2014